ArticleScientific reports2021

Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2.

Jianhua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.